RSC Pharmaceutics has reached an important milestone – its first Journal Impact Factor of 5.5. The work focusses on emerging technologies, including drug delivery, precision medicine and enhanced drug targeting, with potential to drive real change in health. Discover our metrics ➡ buff.ly/Os2BVlM
Interested in becoming a reviewer for the RSC? Find out more here: 🔗 www.rsc.org/publishing/j...
RSC Pharmaceutics would like to thank all of our reviewers for helping to preserve quality and integrity in pharmaceutics literature. We would also like to highlight the Outstanding Reviewers for RSC Pharmaceutics in 2025 🌟
Find out who they are in this Editorial: 🔗 doi.org/10.1039/D6PM...
Tackling antibiotic resistance with nanotechnology 🧪
This review explores how silver nanoparticles can enhance antibiotic efficacy - particularly alongside vancomycin - to tackle resistant bacterial infections.
Read for free here: pubs.rsc.org/en/content/a...
Check out this recent article by Alice Parkes and co-workers:
By tuning spray drying conditions, the work demonstrates improved stability in co‑amorphous drug–drug systems, offering a route to more efficient formulations 💊
Read it for free here: pubs.rsc.org/en/content/a...
We are delighted to introduce our new RSC Pharmaceutics Advisory Board member, Dr. Defang Ouyang 📢
Dr Defang Ouyang is an Associate Professor at the University of Macau. Find out more in our blog post: blogs.rsc.org/pm/2026/05/1...